MS
TLSIW icon

Maven Securities’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Maven Securities’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48,665
Closed -$25K – 1104
2021
Q4 		$25K Sell
48,665
-2,626
-5% -$2.41K ﹤0.01% 807
2021
Q3 		$42K Buy
51,291
+16,666
+48% +$15.5K ﹤0.01% 1014
2021
Q2 		$41K Buy
+34,625
New +$34.2K ﹤0.01% 997

Other funds holding TLSIW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Maven Securities's TLSIW Position: Q1 2022 in Review

Maven Securities sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2022, closing a stake of 48,665 shares — an estimated $25K sold.

Maven Securities first reported a position in TLSIW in Q2 2021 and held it in 3 quarters. The position peaked at $42K in Q3 2021. 26 funds tracked by Wall St. Rank hold TLSIW as of Q1 2022.

  • Maven Securities reported no remaining TriSalus Life Sciences Warrant position as of Q1 2022 after selling out during the quarter.
  • Maven Securities sold 48,665 TriSalus Life Sciences Warrant shares in Q1 2022, an estimated $25K.
  • Maven Securities first reported a position in TriSalus Life Sciences Warrant in Q2 2021 and held it in 3 quarters.
  • Maven Securities's TriSalus Life Sciences Warrant position peaked at $42K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2022.

Based on Maven Securities's 13F filing for Q1 2022, filed 16 May 2022.